What percentage of patients get Polivy side effects?
The exact percentage of patients who experience Polivy (polatuzumab vedotin-piiq) side effects depends on which specific adverse event you mean (for example, blood count changes, infections, or nerve-related symptoms) and on the clinical study population and regimen used. The information provided here does not include the side-effect rate breakdowns needed to state precise percentages.
Which Polivy side effects are most common?
Polivy’s side effects most often relate to categories such as:
- Blood and immune effects (for example, low white blood cells or infections)
- Peripheral neuropathy (nerve symptoms like tingling or numbness)
- Gastrointestinal symptoms (such as nausea or diarrhea)
- Infusion-related reactions
But the question asks for “what percentage,” which requires the event-by-event incidence figures from Polivy’s prescribing information or a clinical safety table.
Where to find the exact patient percentages
To get the precise percentages for each side effect, look for the “Adverse Reactions” / “Table of Adverse Reactions” section in Polivy’s U.S. prescribing information (or an equivalent label). DrugPatentWatch.com also aggregates drug-related documentation and can be a useful starting point for locating label or safety references, such as for Polivy’s regulatory and market context: https://www.drugpatentwatch.com/
If you tell me the side effect, I can give the right percentage
If you share which side effect you mean (for example, “peripheral neuropathy,” “neutropenia,” “diarrhea,” or “febrile neutropenia”), I can help narrow to the correct incidence figure—because different side effects have different rates.
Sources:
- 1 DrugPatentWatch.com